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Abstract 
Eczema, or atopic dermatitis, is a complex and chronic condition that affects 
approximately 10% of children throughout the United States (Brown et al., 2018). The 
American Academy of Allergy Asthma & Immunology (AAAAI) (2017) estimates the 
average cost of eczema management for each patient is approximately $3,302 per year. 
The complex nature of atopic dermatitis indicates a need for individualized treatment 
plans. Research has shown that standardized patient teaching, written education 
materials, and Eczema Action Plans (EAP) reinforce patient teaching, parental 
understanding, and improve quality of life. This evidence-based practice (EBP) project 
introduces the use of a written Eczema Action Plan, using the template created by the 
American Academy of Dermatology (AAD), for patients less than 18 years of age at 
multiple private allergy clinics in California and Washington. The EAP provides written 
instruction for how to cleanse and moisturize skin when symptoms are controlled and 
during a flare, what medications should be used during a mild and moderate flare, and 
what symptoms should prompt the patient to follow up with their allergist. The 
implemented clinical intervention included providing an individualized EAP, in addition 
to standardized written education materials about eczema and its treatment compiled into 
one handout from the National Institute of Health (NIH) and the AAAAI to the parent or 
caregiver of the pediatric patient. Patient outcomes were measured using the University 
of Nottingham’s validated Patient Oriented Eczema Measure (POEM) form and parental 
outcomes were measured using Parental Self-Efficacy Care Index (PAESCI) survey at 
the introduction of the EAP and again at 6-9-weeks post-intervention. Of the 24 
participants enrolled, 20 completed the study. Patient ages ranged from 9 months to 17 
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years. PAESCI scores increased from an average of 47/70 pre-intervention to 60.9/70 
post-EAP use, indicating increased caregiver self-efficacy. POEM scores decreased from 
an average of 8.65/28 pre-EAP to 4.1/28 post-EAP, indicating a reduction in eczema 
severity. At the time of receiving the EAP, parents had an average understanding of 
8.9/10. This increased to an average understanding of a 9.65/10 after using the EAP for 6-
9 weeks, indicating increased understanding after use. Benefits of EAPs along with 
written education materials include reduction of patient costs on office visits and 
medications due to flares, improved medication adherence, improved patient and 
caregiver understanding, and improved patient quality of life. Use of an EAP within an 
allergy clinic can also allow for better continuity of care between the patient’s primary 
care providers and their allergists.  
Keywords: eczema action plan, pediatric atopic dermatitis, allergy, caregiver self-
efficacy, POEM, PASECI  
ATOPIC DERMATITIS IN ALLERGY: USE OF AN ECZEMA ACTION PLAN 5 
 
Managing Pediatric Atopic Dermatitis in the Allergy Clinic: Use of an Eczema Action 
Plan to Improve Caregiver Understanding and Self-Efficacy 
Background and Evidence for Problem 
Eczema, or atopic dermatitis, is a complex and chronic condition that affects 
approximately 10% of children throughout the United States (Brown et al., 2018). This is 
a dynamic, multifactorial condition with periods of acute exacerbations that can vary in 
severity. The nature of atopic dermatitis requires a treatment plan that is effective in 
keeping the symptoms at bay and one that can manage acute exacerbations to prevent 
complications such as infection (Brown et al., 2018). It is recommended by the American 
Academy of Dermatology (AAD) that atopic dermatitis treatment plans involve skin care 
regimens, methods for control of itching and inflammation, as well as management of 
allergic triggers and infection (Brown et al., 2018).  There is a high correlation between 
eczema and other atopic conditions including food and environmental allergies, so it is 
common for pediatric allergists to manage all atopic conditions presented by the patient. 
At this time, there is no standardization for treatment of pediatric eczema in the United 
States, which can lead to inconsistent management of care from the provider and the 
child’s parent or caregiver.  
The American Academy of Allergy, Asthma & Immunology (AAAAI) (2017) 
estimates the average cost of eczema management for each patient is approximately 
$3,302 per year. These costs can be attributed to visits with a provider in primary care, 
allergy, or dermatology, eczema-friendly cleansing and skincare products, and 
prescription medications (AAAAI, 2017). In addition to the high cost of care, the burden 
of atopic dermatitis has also been found to negatively impact a person’s quality of life. 
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On average, patients experience a flare for 100 days out of the year (Sauder et al., 2016). 
Parents of children with eczema often feel unsupported by their providers in treatment of 
their child’s eczema and frequently feel that they are not provided with adequate 
information to manage the condition at home (Powell et al., 2018).  Uncontrolled eczema 
symptoms of itching, bleeding, pain, and sleep disturbance can lead to limitations of 
physical activity, social function, and can adversely affect a child’s emotional state 
(Drucker et al., 2017). It is crucial for providers to create a customized and 
comprehensive treatment plan for a child with atopic dermatitis to achieve a reduction in 
flares. It is equally as important for those caring for a child with atopic dermatitis to have 
an adequate understanding of the treatment plan to effectively manage eczema symptoms 
to mitigate the damaging effect this chronic condition can have on a child’s quality of 
life.  
Proposed Evidence-Based Solutions 
A literature review was conducted using key words including eczema action plan, 
eczema management, atopic dermatitis, atopic dermatitis management, and eczema 
patient education. CINAHL, PubMed, JSTOR, Cochrane, and Ovid databases were 
searched. 27 articles were found to be pertinent and reviewed. 17 articles were utilized 
for the Evidence-Based Practice (EBP) project. Evidence-based solutions proposed by the 
reviewed articles included use of standardized patient education, written education 
materials, and written action plans.  
Standardized Education Materials 
Standardized education materials for all pediatric patients with atopic dermatitis 
within a specified clinical setting were shown to be effective for improving quality of life 
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and caregiver understanding across several studies. A randomized controlled trial of 134 
parents of children with moderate to severe atopic dermatitis measured the change in 
severity of eczema symptoms using the Scoring Atopic Dermatitis (SCORAD) index and 
the quality of family life using the Family Dermatology Life Quality Index (FDLQI) after 
the implementation of a structured short-term parent education program (Pustisek et al., 
2016). The education program consisted of written materials that included a 
corticosteroid use diary and an educational booklet on eczema (Pustisek et al., 2016). The 
participants also received a lecture that included information presented by dermatologists, 
psychologists, a dietician and was followed by nurse-led education (Pustisek et al., 2016). 
The parents in the intervention group reported a significant improvement in the quality-
of-life index (Pustisek et al., 2016). While there was no significant improvement in the 
severity of symptoms for the intervention group, it was noted that the control group 
sought out additional information on eczema to educate themselves on their child’s 
condition (Pustisek et al., 2016).  
A randomized controlled trial of 542 pediatric patients with moderate to severe 
atopic dermatitis also measured the change in disease severity using the SCORAD index 
as well as the quality of life with the Children’s Dermatology Life Quality index 
(IDQOL) pre- and post-intervention of four once-weekly group education sessions (Liang 
et al., 2018). The intervention group showed a significant improvement in eczema 
severity and understanding of emollient use when compared to the control group (Liang 
et al., 2018).  Additionally, a systematic review of 10 randomized controlled trials 
reviewing psychological and educational interventions for atopic dermatitis in children 
revealed an overall increase in quality of life and decrease in symptoms after the 
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implementation of nurse-led, multi-disciplinary, or medically led education focused on 
the child’s parent (Ersser et al., 2017). These studies reveal that structured eczema 
education materials can help to ensure patients receive comprehensive eczema education 
needed to adequately care for the condition outside of the office.  
Written Education Materials and Eczema Action Plans 
Research has shown that another potential evidence-based solution for the deficit 
in pediatric eczema education is the use of written education materials and more 
specifically, eczema action plans. A meta-analysis of 287 eczema studies was conducted 
to provide guidelines for successful treatment of atopic dermatitis (Sidbury et al., 2014).  
The meta-analysis concluded that written education materials were found to reinforce 
teaching and recommended their use to prevent and manage disease flares (Sidbury et al., 
2014). A randomized controlled trial of 211 caregivers of children with eczema 
concluded that providers who utilized an eczema care plan documented more 
comprehensive eczema care than the control group providers (Rea et al., 2018b).  Better 
documentation of a care plan can improve continuity of care, patient understanding, and 
patient outcomes (Rea et al., 2018b). Rea et al. (2018a) also reported that in a cross-
sectional analysis of 224 pediatric patients with a diagnosis of eczema, a greater 
understanding of a child’s individualized eczema plan was associated with a higher 
quality of life. These conclusions were mirrored in a meta-analysis of 388 articles 
exploring the use of written action plans (WAP) in management of children with atopic 
dermatitis (Chilsom et al., 2008). Written action plans been proven to be a useful tool in 
managing other chronic pediatric atopic conditions such as asthma and were proposed to 
be an ideal choice for management of atopic dermatitis (Chilsom et al., 2008). The goal 
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of a written action plan is to provide parents with a step-approach guide to manage their 
child’s chronic condition (Chilsom et al., 2008). The findings concluded the use of WAPs 
in the care of children with atopic dermatitis has substantial potential for improving both 
adherence and outcomes (Chilsom et al., 2008).  
A randomized controlled trial of 37 pediatric patients measured eczema symptom 
severity and quality of life using a 10-question survey with a five-point Likert-type scale 
before and after receiving education with a written Eczema Action Plan (EAP) (Brown et 
al., 2018). Brown et al. (2018) reported a significant increase in understanding of atopic 
dermatitis when compared to the control group. In addition, 90% of the patients who 
received an EAP felt it was easy to understand and 100% reported they would like to 
continue to use this tool (Brown et al., 2018). Similarly, Gilliam et al. (2016) reported 
that in a randomized controlled trial of 88 pediatric patients, parents of children with 
atopic dermatitis who received an EAP were more confident managing their child's atopic 
dermatitis over time as compared with those who did not receive the EAP. Another 
randomized controlled trial of 44 pediatric patients detected poor patient compliance with 
eczema treatments and explored the use of an EAP to reduce Eczema Area and Severity 
Index (EASI) (Sison et al., 2018).  Results of the study showed that at four weeks post-
intervention, statistically significant reductions in EASI scores of the group who received 
the EAP were present (Sison et al., 2018). Conclusions were drawn that an EAP is a 
promising tool that can be utilized to improve severity of eczema symptoms and patient 
compliance with eczema management (Sison et al., 2018).  
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Gap Analysis 
The pre-intervention data from eczema education studies show that patients are 
sent home from office visits without adequate knowledge of atopic dermatitis 
management resulting in increased eczema symptoms and decreased quality of life. This 
is in part due to the complex and multifactorial nature of atopic dermatitis, as well as a 
lack of an all-inclusive approach to managing eczema in children. The post-intervention 
data from these same studies revealed that the use of structured patient education and 
written education materials in the form of an individualized Eczema Action Plan were 
effective in improving caregiver understanding, patient and family quality of life, and 
reducing eczema symptom severity. In January 2020, the selected private allergy clinic 
saw 43 patients with a diagnosis of L20.9 (Atopic Dermatitis) at their Fremont location, 
27 of which were patients less than 18 years old. All of these patients received the 
standard eczema education of verbal instructions presented to the child’s caregiver. This 
patient analysis showed that there was an adequate sample size to justify implementation 
of an evidence-based practice (EBP) intervention for eczema patient education to 
incorporate individualized written education materials. The overarching goals of this 
project were to reduce severity of patient’s atopic dermatitis symptoms and to increase 
parental self-efficacy regarding at-home management of their child’s atopic dermatitis 
through improved patient education methods.  
Description of EBP Project 
Project Overview 
This EBP project was conducted at a private allergy practice utilizing the patient 
population from five of their locations throughout the California and Washington areas. 
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Four providers directly participated in the intervention, alongside the Doctor of Nursing 
practice (DNP) candidate, five nurses, and three medical assistants. An office manager, 
nursing supervisor, and the chief executive officer (CEO) were also involved for 
administrative support of the project. Patients less than 18 year of age with a pre-existing 
diagnosis of atopic dermatitis and an upcoming follow-up, allergy testing, or allergy 
treatment appointments were identified by the DNP candidate as potential study 
participants. New diagnoses of atopic dermatitis were identified by participating 
providers during new patient and follow-up appointments as potential participants. 
During the office visit, the DNP candidate or provider would introduce the patient 
and caregiver to the study and determine potential participant interest. A packet of initial 
patient forms was given for the patient’s parent to complete during the appointment after 
interest in voluntary participation of the study was expressed. This packet consisted of a 
participant demographic questionnaire, a Patient-Oriented Eczema Measurement (POEM) 
form to obtain a baseline eczema severity score for the patient at the time of the visit, and 
Parental Self-Efficacy with Eczema Care Index (PASECI) form to obtain baseline 
parental comfort with caring for a child with eczema (see Appendix E). At the end of the 
visit, the provider or DNP candidate presented the parent with a physical copy of the 
completed Eczema Action Plan designed by the American Academy of Dermatology 
(AAD), or an electronic copy, as shown in Appendix D, through the patient messaging 
portal. The parent also received a handout of written eczema education materials, created 
by the DNP student with input from the providers using materials from the National 
Institute of Health (NIH) and American Academy of Allergy, Asthma, & Immunology 
(AAAAI) (see Appendix E). After receiving the EAP, the parent was asked to complete a 
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Caregiver’s Comprehension of Eczema Action Plan questionnaire (see Appendix E). The 
parent was also given a post-intervention packet containing a POEM form, PASECI 
form, and Caregiver’s Comprehension of Eczema Action Plan questionnaire with 
instruction that the DNP candidate would follow up in six weeks. The parent was 
informed that another copy of these forms would be sent via the email provided on the 
demographics form and the clinic’s online patient portal. Average response time for 
return of the post-intervention forms was 6.7 weeks. Pre- and post-intervention data were 
collected on a spreadsheet in the clinic’s secure Google Drive. Completed Eczema Action 
Plans were scanned into the patient’s charts by the nurses and medical assistants. The 
EAPs would be visible to providers at all clinic locations to assist with continuity of care.  
Measurements and Outcomes  
This EBP project used three measures to evaluate project outcomes. The first 
outcome to be measured was the change in eczema severity pre- and post- EAP use. This 
outcome would be measured using the University of Nottingham’s widely accepted 
Patient-Oriented Eczema Measure scale, which inquiries about patient symptoms over a 
one-week period with the use of seven questions and a total potential score of 28. The 
POEM scale was chosen due to provider familiarity within the allergy clinics. In the case 
of this scale, a score of 28 indicates severe eczema, while a score of zero represents no 
current symptoms. The next outcome to be measured was parental comfort with 
managing their child’s eczema pre- and post- intervention. This outcome was to be 
measured using the Parental Self-Efficacy with Eczema Care Index, a seven-question 
survey using a 10-point Likert-scale, with a potential total score of 70. Ersser et al. (2015) 
demonstrated that their 29-item PASECI scale had “face, content and construct validity 
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and reliability,” (p.1483) with Cronbach’s Alpha values of 0.906, 0.874, 0.915 and 0.953 
across the four domains assessed when tested in a 242-parent focus group. The seven-
question survey tool for this project has a calculated Cronbach’s Alpha score of 0.96 
indicating excellent internal consistency. A total score of 70 on the seven-question 
PASECI survey indicates total self-efficacy with a child’s eczema management, while a 
score of zero indicates a lack of self-efficacy. The last outcome measured was the degree 
of parent or caregiver understanding of the presented EAP. This outcome was measured 
using a one question 10-point Likert-scale survey with a total potential score of 10. The 
maximum score of 10 indicated complete comprehension of the EAP, while a score of 
zero indicated no understanding. Measurements on all three outcomes were to be taken at 
the time of receiving the EAP, and six weeks post-EAP. 
Anticipated Outcomes 
Based on the reported findings from randomized controlled trials reviewed in the 
literature search, there were several anticipated positive impacts of the EBP project. Short 
term goals following the implementation of written education materials and an EAP for 
pediatric patients with a diagnosis of atopic dermatitis at the allergy clinics would ideally 
reduce eczema severity as indicated by a reduction in POEM scores and increase parental 
understanding of the condition as indicated by an increase in PAESCI scores. The third 
goal was for there to be an adequate parental understanding of the provided EAP. Other 
anticipated benefits of the project that would not be directly measured included patient 
improvement in health literacy regarding atopic dermatitis, better control of eczema 
resulting in a decreased need for follow up visits due to eczema flares, and better 
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continuity of care with provider use of a standardized and complete action plan and use 
of eczema severity index scales to gauge success of treatment protocols.  
PICOT Question 
In allergy clinic patients less than 18 years of age with a diagnosis of atopic 
dermatitis (eczema) (P), does implementing the use of written education materials to the 
patient’s caregiver/parent in the form of an Eczema Action Plan in addition to verbal 
teaching (I), compared to the standard verbal teaching (C), result in a decrease in severity 
of patient reported eczema symptoms measured by the POEM form and increased 
parental self-efficacy of at-home eczema management measured by the Parental Self-
Efficacy Index (O) within 6-10 weeks (T)?  
EBP Model 
The Iowa Model was selected as the evidence-based practice (EBP) model for 
implementing an Eczema Action Plan for pediatric patients with atopic dermatitis at an 
allergy clinic. The identified evidence-based practice project involved implementing a 
new eczema education process within an allergy clinic. Using the Evaluation Criteria for 
the EBP Model chart provided by Gawlinski and Rutledge (2008), several EBP models 
were compared for potential use. Upon comparison of the Iowa Model, Stetler Model, 
ACE Star Model and Johns Hopkins Nursing Model, the Iowa Model scored the highest 
against the six evaluation criteria. The Iowa Model was clear and concise, allowed quick 
assimilation of concepts, was comprehensive throughout, easy to use in a clinical setting, 
and applied well to the selected project (Gawlinski & Rutledge, 2008). The Iowa Model 
has a strong emphasis on organizational process, and therefore is a good fit for guiding 
this EBP project (Gawlinski & Rutledge, 2008).  
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Project Process Plan 
The EBP project was set into motion with a letter of support provided by the CEO 
and Founder of the allergy practice on March 6, 2020. The letter of support allowed for 
use of data from the clinic-site for an evidence-based class project and possible 
presentations and publications. This was followed by a letter indicating University of San 
Diego (USD) faculty approval on April 29, 2020. USD Institutional Review Board 
approval of exempt status was obtained on May 8, 2020. The DNP candidate provided 
staff training on proper implementation of the EBP project July 28, 2020 through July 31, 
2020. Implementation of the use of written education materials and the EAP began on 
August 27, 2020 along with data collection. Additional provider education presented by 
the DNP candidate took place on September 22, 2020. A total of 24 patients from 
California and Washington locations volunteered to participate in this EBP project. The 
DNP candidate presented the opportunity to participate in the study to patients who met 
the inclusion criteria. Willing providers at select clinic locations completed the EAP form 
for enrolled patients. The DNP candidate followed up with the parent/caregiver in person, 
by phone, email, or patient messaging system at the end of the initial appointment to 
provide additional education as needed. At six weeks post intervention, participants were 
contacted by means of email, telephone, text message, or patient messaging system to 
complete post-EAP forms including the POEM, PAESCI and parental understanding of 
the EAP forms. 20 of the 24 enrolled patients completed the post intervention survey. 
Four patients were lost to follow-up for undetermined reasons. Data collection concluded 
January 23, 2020. Data analysis took place January 23, 2021 through January 29, 2021.  
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Results 
A total of 10 female and 10 male patients between the ages of nine months and 17 
years participated in the study, 75% of whom were of Asian and Southeast Asian descent 
(see Figure 1).  Breakdown of the number of patients in each age range can be found in 
Table 1. 35% of participants had one other atopic condition, 35% had two other atopic 
conditions, and 20% had asthma, hayfever, and food allergies as comorbid atopic 
conditions (see Table 2). 70% of patients had a family history of one or more atopic 
conditions. 19 of the 20 study participants had pre-existing diagnosis of atopic dermatitis 
for more than one year (see Table 4), and only two of the participants had previously 
used an EAP (see Table 5). 
At the initial visit, POEM scores for the 20 participants averaged an 8.6/28, 
indicating most patients had moderate eczema. Six to nine weeks post-EAP, average 
POEM scores decreased to 4.1, indicating an improvement in eczema severity to mild 
after the use of an EAP and written education materials (see Figure 2). The most common 
eczema symptoms experienced for the 20 participants pre- and post-EAP were itchy skin 
and rough skin (see Figure 4). A reduction in the average number of days of symptoms 
was experienced across the patient population.  PASECI average scores increased by 13.2 
points, from 47.7/70 to 60.9/70, indicating an overall improvement in parental self-
efficacy with caring for their child’s eczema (see Figure 3). Parents initially felt most 
confident in their ability to apply moisturizer to their child with eczema. Parents noted an 
increased self-efficacy across all patients in all areas of eczema management 6-9 weeks 
post-EAP (see Figure 5), with comfort in managing infected skin having the most 
significant improvement post-EAP. This shows the AAD EAP’s specific instructions to 
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call the dermatologist with symptoms of infected skin such as skin weeping or oozing 
pus, painful skin, severe itching, fever, or chills helped to increase parental comfort with 
managing this complication. 85% of parents scored their understanding of the EAP at an 
8/10 or better (see Table 6). After using the EAP for 6-9 weeks, the parent’s felt that they 
understood the EAP even better as indicated by an increased average score of 9.65/10 
from 8.9/10 (see Figure 6). This indicates that the chosen EAP format was easy to 
understand and an effective tool for educating parents on caring for their child’s eczema.   
Dissemination 
Collected data and results from the EBP project were presented at a stakeholder 
meeting which took place virtually via Google Drive Meeting on April 9, 2021 (see 
Appendix C).  Meeting attendees included the DNP candidate, the allergy clinic’s CEO 
and founder, clinical manager, and the USD clinical faculty. A poster summary of the 
project (see Appendix B) and the results were emailed out to the providers and charge 
nurses at all the company’s clinic locations throughout California, Idaho, Oregon, and 
Washington. The Eczema Action Plan form and eczema handouts were included in this 
email and uploaded to the company’s Google Drive. The findings from this EBP project 
were also presented to USD DNP candidates and their faculty advisors at the DNP 
Presentation Day event on March 4, 2021. A poster presentation of this EBP project took 
place at the Western Institute of Nursing (WIN) conference held virtually April 14-16, 
2021 (see Appendix A).  
Cost-Benefit Analysis 
Current costs for the standard verbal education only for pediatric eczema patients 
at the allergy clinic are $0. Total project costs for the implementation of the EAP and 
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written eczema education materials for 20 study participants were approximately $528. 
These costs included an estimated $480 for salary costs related to time needed for staff 
training of providers, nursing staff, and medical assistants, and $48 for printing of the 
patient forms. Potential financial benefits for the clinic with this intervention include 
being able to bill for atopic dermatitis as a problem for the visit, and potentially increase 
the total number of problems addressed at the visit to bill at a higher level, if appropriate. 
The estimated average cost of eczema treatment per year is $3,302 per patient per year, 
$1,060 of which are out of pocket costs (AAAAI, 2017 & Zink et al., 2019). A reduction 
in severity of eczema symptoms due to increased caregiver understanding of the 
condition and a clear treatment plan could help to reduce the number of unnecessary 
eczema treatments and office visits due to flares and reduce the number of ineffective 
over-the-counter products used. In a program size of 20 patients, for every dollar spent 
there is an estimated $18.71 cost savings for the patients. In a program size of 20 patients, 
there would be a 1771.21 % ROI. 
 Non-financial benefits of the project include implementation of a streamlined 
process for managing eczema at the allergy clinics to allow for seamless transition of care 
between providers at these locations. More comprehensive documentation with an 
emphasis on patient education practices and ensuring patient understanding could 
improve medication adherence and as a result improve patient morale and satisfaction.  
Sustainability 
The low costs associated with the startup and maintenance of the project make 
this a promising EBP intervention to implement long-term at the allergy clinics. There is 
evidence to support use of an Eczema Action Plan and written education materials as a 
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facility guideline for managing atopic dermatitis in the pediatric allergy setting. It is 
recommended for use of an EBP to be written in as a new guideline and staff training 
should be performed to educate all providers and medical personnel on the guideline. A 
charge nurse or provider should be appointed as a lead at each location to ensure proper 
and consistent use of the education materials for the first six months the new guideline is 
enforced. As patients become familiar with the EAP and receiving written materials, it 
will become an expectation to receive these tools at each visit.  
Implications for Clinical Practice 
This study confirms that the use of an EAP, when followed, can improve parental 
confidence in appropriately managing their child’s eczema and reduce the severity of 
their child’s eczema symptoms. Utilization of an EAP in combination with written 
education materials provides more comprehensive patient education which can improve 
medication adherence, decrease symptom severity, save money on extra appointments 
and treatment due to flares. Standardized patient education in the form of an EAP creates 
better continuity of care and the results of this study support the recommendation of 
writing this EBP intervention into clinic protocols for management of pediatric atopic 
dermatitis. It is recommended that this project be expanded to the remaining clinic 
locations within company, and in the future the clinic can also consider expanding these 
education methods to adult patients.  
Limitations 
Several limitations arose throughout the duration of the EBP project, a majority of 
which could be attributed to the COVID-19 Pandemic. Several staffing changes occurred 
between the time the letter of support was obtained, the time of staff training, and again 
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when project implementation took place as a result of the financial burden of the 
pandemic. The DNP candidate was only able to enroll 24 participants, 20 of which 
completed the post-intervention documents. The first challenge noted in recruiting 
patients was that many of patients had their atopic dermatitis managed by a dermatologist 
or the pediatrician, so an EAP from someone other than the prescribing provider did not 
seem appropriate. In addition, the pandemic led to a decreased patient volume and most 
appointments were moved to a telehealth format. Telehealth visits tend to be shorter than 
physical office visits, and an increased difficulty was noted when it came obtaining 
patient interest and buy-in through telehealth visits when compared to physical office 
visits. The more hands-off nature of the telehealth visits and the extra steps involved for 
the patient after their appointment of having to send and receive extra documents could 
account for this. Another challenge with recruiting patients was that all written education 
materials were only provided in English. 85% of the 20 participants spoke English as 
their first language, while the remaining 15% selected Mandarin and Nepali and their first 
languages. The final limitation noted for this EBP project was that there was no way to 
account for the affect that the time of year, concurrent allergy treatments, or specific 
allergies had on eczema severity as these data points could potentially lead to a different 
interpretation of the patient outcomes.  
Conclusion 
The use of an individualized Eczema Action Plan along with standardized written 
eczema education materials proved to be an effective intervention for reducing eczema 
severity in patients less than 18 years of age in a private allergy clinic, as indicated by a 
reduction in average POEM severity scores from moderate severity to mild severity 6-9 
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weeks post implementation of the new education materials. These data points also 
showed that there was adequate parental understanding of the Eczema Action Plan, which 
contributed towards increased parental self-efficacy across seven different categories, as 
indicated by an increased average PASECI score 6-9 weeks post intervention. Both short-
term goals for this project were met. The successful completion of the short-term goals in 
addition to the low implementation costs, financial benefits of the project, and non-
financial benefits of the project give support for the recommendation to keep this EBP 
intervention as a new guideline for managing atopic dermatitis in the pediatric population 
at all allergy clinics within the company.  
 
  
ATOPIC DERMATITIS IN ALLERGY: USE OF AN ECZEMA ACTION PLAN 22 
 
References 
American Academy of Allergy Asthma & Immunology. (2017, November 21). How  
expensive is healthcare for atopic dermatitis patients? 
https://www.aaaai.org/global/latest-research-summaries/New-Research-from-
JACI-In-Practice/expensive-dermatitis 
Brown, J., Weitz, N. W., Liang, A., Stockwell, M. S., & Friedman, S. (2018). Does an  
eczema action plan improve atopic dermatitis? A single-site randomized controlled 
trial. Clinical Pediatrics, 57(14), 1624-1629. doi 10.1177/0009922818795906 
Chilsom, S. S., Taylor, S. L., Balkrishnan, R., & Feldman, S. R. (2008). Written action  
plans: Potential for improving outcomes in children with atopic dermatitis. Journal  
of the American Academy of Dermatology, 59(4). 677-683.  
https://doi.org/10.1016/j.jaad.2008.04.025 
Drucker, A. M., Wang, A. R., Li, W. Q., Sevetson, E., Block, J. K., & Qureshi, A. A.  
(2016). The burden of atopic dermatitis: Summary of a report for the national  
eczema association. Journal of Investigative Dermatology, 137, 26-30.  
https://doi.org/10.1016/j.jid.2016.07.012 
Ersser, S. J., Cowdell, F., Latter, S., Gardiner, E., Flohr, S., Thompson, A. R., Jackson,  
K., Farasat, H., Ware, F., & Drury, A. (2014). Psychological and educational  
interventions for atopic eczema in children (Review). Cochrane Database of  
Systematic Reviews, 2014(1). https://doi.org/10.1002/14651858.CD004054.pub3 
Ersser, S. J., Farasat, H., Jackson, K., Gardiner, E., Sheppard, Z. A., & Cowdell, F.  
(2015). Parental self-efficacy and the management of childhood atopic eczema:  
Development and testing of a new clinical outcome measure. British Journal of  
ATOPIC DERMATITIS IN ALLERGY: USE OF AN ECZEMA ACTION PLAN 23 
 
Dermatology, 173, 1479-1485. https://doi.org/10.1111/bjd.14175 
 
Gawlinski, A., & Rutledge, A. (2008). Selecting a model for evidence-based practice  
changes. AACN Advanced Critical Care, 19(3), 291-300.  
https://doi.org/10.1097/01.AACN.0000330380.41766.63 
Gilliam, A. E., Madden, N., Sendowski, M., Mioduszewski, M., & Duderstadt, K. G.  
(2016). Use of eczema action plans (EAPs) to improve parental understanding of  
treatment regimens in pediatric atopic dermatitis (AD): A randomized controlled  
trial. Journal of the American Academy of Dermatology, 74(2). 375-277.  
https://doi.org/10.1016/j.jaad.2015.08.067 
Melnyk, B. M., & Fineout-Overholt, E. (2015). Evidence-based practice in nursing &  
healthcare: A guide to best practice (3rd ed.). Philadelphia: Wolters 
Kluwer/Lippincott Williams & Wilkins. 
Powell, K., Le Roux, E., Banks, J. P., & Ridd, M. J. (2018). Developing a written action  
plan for children with eczema: a qualitative study. The British journal of general  
practice: the journal of the Royal College of General Practitioners, 68(667),  
e81–e89. https://doi.org/10.3399/bjgp17X693617 
Pustisek, N., Situm, M., Zivkovic, M. V., Hadzavdic, S. L., Vurnek, M., & Niseteo, T.  
(2016). The significance of structured parental educational intervention on  
childhood atopic dermatitis: a randomized controlled trial. European Academy of  
Dermatology and Venereology, 30. 806-812. https://doi.org/10.1111/jdv.13519 
Rea, C. J., Tran, K. D., Jorina, M., Wenren, L. M., Hawryluk, E. B., Toomey, S. L.  
(2018). A randomized controlled trial of an eczema care plan. Academic  
Pediatrics, 18(7). 789-796. https://doi.org/10.1016/j.acap.2018.02.015 
ATOPIC DERMATITIS IN ALLERGY: USE OF AN ECZEMA ACTION PLAN 24 
 
Rea, C. J., Tran, K. D., Jorina, M., Wenren, L. M., Hawryluk, E. B., & Toomey, S. L.  
(2018). Associations of eczema severity and patient knowledge with child quality  
of life in a pediatric primary care population. Clinical Pediatrics, 57(13). 1506- 
1514. https://doi.org/10.1177/0009922818787295 
Sauder, M. B., McEvoy, A., & Ramien, L. (2016). Prescribing success: Developing an  
integrated prescription and eczema action plan for atopic dermatitis. J Am Acad  
Dermatol, 75(6). 1281-1283. http://dx.doi.org/10.1016/j.jaad.2016.08.029 
Sidbury, R., Tom, W. L., Bergman, J. N., Cooper, K. D., Silverman, R. A., Berger, T. G.,  
Chamlin, S. L., Cohen, D. E., Cordoro, K. M., Davis, D. M., Feldman, S. R.,  
Hanifin, J. M., Krol, A., Margolis, D. J., Paller, A. S., Schwarzenberger, K.,  
Simpson, E. L., Williams, H. C., Elmets, C. A., . . . Eichenfield, L. F. (2014).  
Guidelines of care for the management of atopic dermatitis. Journal of the  
American Academy of Dermatology,71(6). 1218-1233.  
https://doi.org/10.1016/j.jaad.2014.03.030 
Sison, M. E. G. & Lazo-Dizon, J. P. (2018). Effectiveness of the Eczema Action Plan  
(EAP) in improving the Eczema Area and Severity Index (EASI) scores among  
pediatric patients with atopic dermatitis: A pragmatic randomized controlled trial.  
Journal of the American Academy of Dermatology, 79(3). AB118.  
https://doi.org/10.1016/j.jaad.2018.05.498 
Titler, M. G., Steelman, V. J., Budreau, G., Buckwalter, K. C., & Goode, C. J. (2001).  
The Iowa model of evidence-based practice to promote quality care. Critical Care  
Nursing Clinics of North America, 13(4), 497-509.  
https://doi.org/10.1016/S0899-5885(18)30017-0 
ATOPIC DERMATITIS IN ALLERGY: USE OF AN ECZEMA ACTION PLAN 25 
 
Zink, A. G. S., Arents, B., Fink-Wagner, A., Seitz, I. A., Mensing, U., Wettemann, N., de  
Carlo, G., & Ring, J. (2019). Out-of-pocket costs for individuals with atopic  
eczema: A cross-sectional study in nine European countries. Acta Derm  
Venereol, 99(3). 263-267. https://doi.org/10.2340/00015555-3102  





Ages of Patients in the Study 
 
Age Incidence Percentage 
< 1 year 2 10% 
1-5 years 8 40% 
6-10 years 5 25% 
11-15 years 3 15% 




Comorbid Atopic Conditions  
 
Condition Incidence Percentage 
Asthma only 0 0% 
Hayfever only 0 0% 
Food Allergies only 7 35% 
Asthma & Hayfever only  0 0% 
Asthma & Food Allergies only 1 5% 
Hayfever & Food Allergies only 6 30% 
Asthma, Hayfever & Food Allergies 4 20% 




Family History of Atopic Conditions  
 
Condition Incidence Percentage 
Asthma only 1 5% 
Hayfever only 5 25% 
Food Allergies only 1 5% 
Asthma & Hayfever only  3 15% 
Asthma & Food Allergies only 0 0% 
Hayfever & Food Allergies only 1 5% 
Asthma, Hayfever & Food Allergies 3 15% 
None  6 30% 
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Table 4 
Duration of Eczema Diagnosis  
 
Duration Incidence Percentage 
< 6 months 1 5% 
6 -12 months 4 20% 




Previous Use of Eczema Action Plan  
 
Prior Use of EAP Incidence Percentage 
Yes 2 10% 





Caregiver Understanding of EAP at Initial Visit 
 
Total Score (0-10) Incidence Percentage 
5 0 0% 
6 1 5% 
7 2 10% 
8  4 20% 
9 4 20% 
10 9 45% 







Note: Most patients included this study were of Asian and Southeast Asian  
 







Note: POEM scores decreased by an average score of 4.1, indicating a reduction in 







RACE OF STUDY PARTICIPANTS
































Average POEM Scores Pre/Post EAP





Note: PASECI average scores increased by 13.2 points, indicating an overall 
































Average PASECI Scores Pre/Post 
EAP






Note: The most common eczema symptoms experienced were itchy skin and rough skin. 
A reduction in the average number of days of symptoms was experienced across all 

































































POEM Score Breakdown Per Question
POEM Pre-EAP
POEM Post-EAP






Note: Parents initially felt most confident in their self-efficacy with applying moisturizer 
to their child with eczema and least confident in their self-efficacy with avoiding eczema 
irritants. Parents noted an increased self-efficacy across the board in all areas of eczema 























































PASECI Score Breakdown Per Question Pre/Post EAP
PASECI Pre-EAP PASECI Post-EAP




Note: On average, parents scored 8.9/10 for their understanding of the Eczema Action 
Plan after immediately receiving the EAP. After using the EAP for 6-9 weeks, the 






























Caregiver's Comprehension of Eczema Action Plan




Poster Abstract with Letter of Acceptance to Conference 
Abstract 
Managing Pediatric Atopic Dermatitis in the Allergy Clinic: Use of an Eczema 
Action Plan 
Eczema, or atopic dermatitis, is a complex and chronic condition that affects 
approximately 10% of children throughout the United States (Brown et al., 2018). The 
American Academy of Allergy Asthma & Immunology (AAAI) (2017) estimates the 
average cost of eczema management for each patient is approximately $3,302 per year. 
The complex nature of atopic dermatitis indicates a need for individualized treatment 
plans. Research has shown that standardized patient teaching, written education 
materials, and Eczema Action Plans (EAP) reinforce patient teaching, parental 
understanding, and improve quality of life. This evidence-based practice project 
introduces the use of a written EAP, using the template created by the American 
Academy of Dermatology (AAD), for patients less than 18 years of age at multiple 
allergy clinics in California and Washington. The implemented clinical intervention 
included providing an individualized EAP, in addition to standardized written education 
materials about eczema and its treatment compiled into one handout from the National 
Institute of Health (NIH) and the AAAI to the parent or caregiver of the pediatric patient. 
Patient outcomes were measured using the University of Nottingham’s validated Patient 
Oriented Eczema Measure (POEM) form and parental outcomes were measured using 
Parental Self-Efficacy Care Index (PAESCI) survey at the introduction of the EAP and 
again at 6-8-weeks post-intervention. Results are pending. Benefits of EAPs along with 
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written education materials include reduction of patient costs on office visits and 
medications due to flares, improved medication adherence, improved patient and 
caregiver understanding, and improved patient quality of life. Use of an EAP within an 
allergy clinic can also allow for better continuity of care between the patient’s primary 
care providers and the allergists.  
 
Keywords: eczema action plan, pediatric atopic dermatitis, allergy, caregiver self-
efficacy, POEM, PASECI 
 








































DNP Program Outcomes Exemplars 













Foundation Competencies  
 
The scientific foundation of 
nursing practice has expanded 
and includes a focus on both the 
natural and social sciences 
including human biology, 
genomics, science of therapeutics, 
psychosocial sciences, as well as 
the science of complex 
organizational structures. In 
addition, philosophical, ethical, 
and historical issues inherent in 
the development of science create 
a context for the application of 

























nursing and other 
scientific and 
ethical theories and 
concepts to create 

































● Developed a scientific 
understanding of human biology 
and disease processes through an 
Advanced Pathophysiology 
course (ANPC 520, Fall 2018) 
● Explored the history of 
vaccinations, incidence and 
prevalence of disease and 
relevant historical information 
related to health care through an 
Epidemiology course (DNPC 
625, Fall 2018) 
● Gained an understanding of how 
to synthesize research related to 
health care and utilize evidence-
based practice through a 
Methods of Translational 
Science course (DNPC 611, Fall 
2018) 
● Developed a scientific 
understanding of pharmacology 
and best practice in prescribing 
medications about multiple 
conditions in a Pharmacology in 
Health Management course 
(ANPC 523, Spring 2019) 
● Demonstrated an understanding 
of reflective practice and 
professional development in 
advance practice nursing through 
discussions, readings, and 
practice with written narratives 
(DNPC 610, Summer 2019) 
● Applied knowledge of advanced 
pathogenesis and clinical 
genetics in the evaluation of 
patients with multi-system 
disease states through a mock 
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nursing and other 
scientific and 
ethical theories and 
concepts to create 









































genetic case conference 
presentation and Evidence-Based 
Synthesis & Pathogenesis 
Presentation & Manuscript 
(DNPC 622, Fall 2019) 
● Gained knowledge of 
developmental and health 
screening methods across the 
lifespan and appropriate patient 
interview techniques and applied 
these concepts within the context 
of a Primary Care Clinical 
Setting (NPTC 602, Fall 2019).  
● Gained an understanding of how 
to appropriately assess all body 
systems of patients throughout 
the lifespan to gain subjective 
and objective information 
needed to create an assessment 
and plan. Practiced application 
of these skills through weekly 
labs, OSCEs, and the primary 
care clinical setting (APNC 521, 
Fall 2019) 
● Continued to build a foundation 
of primary care theory through 
lecture, OSCEs, and hands-on 
application of common acute and 
chronic conditions throughout 
the lifespan for each body 
system at a primary care clinical 
site (NPTC 604, Spring 2020) 
● Continued to build a foundation 
of primary care theory through 
lecture and OSCEs on pediatric, 
neuro, OB/GYN, hematologic, 
endocrine, metabolic, 
pulmonary, and cardiac 
conditions as well as topics such 
as ethical principles to managing 
patients with advanced stage 
heart failure, maintaining 
privacy during telehealth, 
nutrition management (NPTC 
605, Summer 2020) 
● Continued to build a foundation 
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nursing and other 
scientific and 
ethical theories and 
concepts to create 




of primary care theory through 
lecture and OSCEs on eye, 
orthopedic, cardiac, neurologic, 
women’s health, GI, male GU, 
and dermatologic conditions 
(NPTC 608, Summer 2020) 
● Continued to build on the 
foundation for conditions 
managed in primary care through 
theory, OSCEs, and clinical 
application of common complex 
and/or unstable acute and 
chronic health problems across 
the lifespan (NPTC 609, Spring 
2021) 
DNP Essential II: 
Organizational & System 
Leadership for Quality 








Advanced nursing practice 
includes an organizational and 
systems leadership component 
that emphasizes practice, ongoing 
improvement of health outcomes, 
and ensuring patient safety. 
Nurses should be prepared with 
sophisticated expertise in 
assessing organizations, 
identifying system’s issues, and 
facilitating organization wide 
changes in practice delivery. This 
also requires political skills, 
systems thinking, and the business 
and financial acumen needed for 
the analysis of practice quality 












systems that meet 























● Built a foundation for tools and 
processes involved in quality 
improvement in health care and 
strategic planning through a 
Strategic Planning and Quality 
Initiatives Course. Applied this 
knowledge through an individual 
project analyzing a case study 
regarding overuse of antibiotics 
(DNPC 626, Spring 2019). 
● Built a foundation of awareness 
of Health Policy and how to 
become involved through a 
Health Policy course (DNPC 
658, Spring 2019). Within this 
course submitted a policy 
proposal to the ANA regarding 
overuse of medical tests   
● Worked towards improving 
patient care using reflective 
practice (DNPC 610, Summer 
2019). Gaining the ability to 
critically reflect on my own 
actions and experiences has 
allowed me to connect with my 
patient and lead a team more 
effectively.  
● Developed a business plan for a 
product/service to improve 
current health care practices 
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DNP Essential II: 
Organizational & System 
Leadership for Quality 














systems that meet 




including evaluation of current 
and similar product/services and 
presented the idea to peers and 
professors (DNPC 653, Summer 
2019) 
● Created a sample evidence-based 
practice project including 
conducting a literature review 
and critically evaluating the 
evidence, writing a PICOT 
question, researching 
conferences available to present 
the results to, and creating a 
mock stakeholder presentation 
(DNPC 686, Spring 2020)  
● Gained experience in ensuring 
patient safety while caring for 
patients with common conditions 
in a primary care setting through 
an understanding of red flag 
symptoms for common 
conditions, ethical principles, 
and informed consent (NPTC 
604, Spring 2020) 
● Continued to develop leadership 
skills through review of ethical 
principles, APRN scope of 
practice, and standards and 
guidelines for providing clinical 
care (NPTC 605 & 608, Summer 
2020) 
● Created and implemented an 
evidence-based practice project 
on use of an Eczema Action Plan 
in allergy clinics. This included 
conducting a literature review 
and critically evaluating the 
evidence, writing a PICOT 
question, implementing the use 
of an EAP for patients < 18, 
creating a stakeholder 
presentation, and presenting at 
the WIN conference (DNPC 




DNP Essential III: Clinical 
Scholarship & Analytical 
Methods for Evidence-




Inquiry Competencies  
 
Scholarship and research are the 
hallmarks of doctoral education. 
Although basic research is viewed 
as the first and most essential 
form of scholarly activity, an 
enlarged perspective of 
scholarship has emerged through 
alternative paradigms that 
involve more than discovery of 
new knowledge. These paradigms 
recognize: (1) the scholarship of 
discovery and integration 
“reflects the investigative and 
synthesizing traditions of 
academic life”; (2) scholars give 
meaning to isolated facts and 
make connections across 
disciplines through the 
scholarship of integration; and 
(3) the scholar applies knowledge 
to solve a problem via the 
scholarship of application that 
involves the translation of 
research into practice and 
dissemination and integration of 

































































● Gained an understanding of how 
to synthesize research related to 
health care and utilize evidence-
based practice through a 
Methods of Translational 
Science course. Applied this 
knowledge through a term paper 
which discussed the analysis of 
articles regarding food allergy 
testing and utilized evidence-
based practice to suggest 
implementation of early food 
allergy detection in at-risk 
children (DNPC 611, Fall 2018) 
● Built a foundation for tools and 
processes involved in quality 
improvement in health care and 
strategic planning through a 
Strategic Planning and Quality 
Initiatives Course. Applied this 
knowledge through an individual 
project analyzing a case study 
regarding evidence-based 
changes to be made to reduce the 
overuse of antibiotics (DNPC 
626, Spring 2019). 
● Developed a business plan for a 
food allergy kit after analyzing 
the current food allergy market 
and products to improve current 
food allergy practices including 
evaluation of current and similar 
products and presented the idea 
to peers and professors (DNPC 
653, Summer 2019) 
● Researched, synthesized, and 
presented Evidence-Based 
guidelines and up-to-date 
information on the pathogenesis 
of selected conditions guide 
peers in the evaluation of 
patients with multi-system 
disease states (DNPC 622, Fall 
2019) 
● Applied theoretical knowledge 
of recommended routine 
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DNP Essential III: Clinical 
Scholarship & Analytical 
Methods for Evidence-
































































































screenings for adults and 
children and recommended 
immunizations throughout the 
lifespan through complete 
physical assessments performed 
at a primary care clinical site 
(NPTC 602, Fall 2019).  
● Gained theoretical knowledge of 
how to properly assess all body 
systems on patients of all ages 
and demonstrated proper 
technique through skills labs and 
OSCEs. Also developed the 
ability to critically think and 
create a list of differential 
diagnoses based on the objective 
clinical findings (APNC 521, 
Fall 2019).  
● Went through the steps of 
developing a mock EBP project 
based on a literature review and 
need for improvement within a 
theoretical clinical site. 
Synthesized the evidence to 
apply the research into a 
theoretical clinical site with an 
EBP model (DNPC 686, Spring 
2020).  
● Utilized current guidelines 
supported by research to 
promote and perform routine 
health screenings during 
complete physical exams within 
a primary care setting (NPTC 
604, Spring 2020) 
● Continued to integrate 
knowledge of pathophysiology, 
pharmacology, and assessment 
skills to develop a list of 
differential diagnoses and 
understanding of primary care 
conditions. Also applied these 
concepts to perform OSCEs on 
Women’s health, respiratory 
conditions, and dermatologic 
conditions (NPTC 605 & 608, 
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DNP Essential III: Clinical 
Scholarship & Analytical 
Methods for Evidence-















practice guidelines.  
Summer 2020) Also applied this 
knowledge to come up with a list 
of meaningful differential 
diagnoses within the laser & 
cosmetic dermatology clinical 
setting (NPTC 605 & 608, Fall 
2020)  
● Gained a theoretical knowledge 
of practice guidelines for 
common complex and/or 
unstable acute and chronic health 
problems including the PERC 
rule, Ottawa Ankle and Knee 
rules, Well’s Criteria, SF 
Syncope, Canadian C-Spine, 
NEXUS, New Orleans CT Rule, 
Sgarbossa’s Criteria, PECARN 
and more (NPTC 609, Spring 
2021) 
● Created and implemented an 
evidence-based practice project 
on use of an Eczema Action Plan 
in allergy clinics. This included 
conducting a literature review 
and critically evaluating the 
evidence, writing a PICOT 
question, implementing the use 
of an EAP for patients < 18, 
creating a stakeholder 
presentation, and presenting at 
the WIN conference (DNPC 
630, Spring 2020-Spring 2021) 
DNP Essential IV: 
Information 
Systems/Technology & 
Patient Care Technology 
for Improvement & 




Technology & Information 






guidelines in the 
delivery of health 
care and the 







● Built a foundation regarding the 
rules, regulations, and 
application of healthcare 
informatics through an 
Introduction to Health Care 
Information Management 
course. Gained hands-on 
experience utilizing Microsoft 
Excel as a tool to be used within 
the health-care system (HCIN 





DNP graduates are distinguished 
by their abilities to use 
information systems/technology to 
support and improve patient care 
and health care systems, and 
provide leadership within health 
care systems and/or academic 
settings. Knowledge and skills 
related to information 
systems/technology and patient 
care technology prepare the DNP 
graduates apply new knowledge, 
manage individual and aggregate 
level information, and assess the 
efficacy of patient care 
technology appropriate to a 
specialized area of practice along 
with the design, selection, and use 
of information systems/technology 
to evaluate programs of care, 
outcomes of care, and care 
systems. Information 
systems/technology provide a 
mechanism to apply budget and 
productivity tools, practice 
information systems and decision 
supports, and webbased learning 
or intervention tools to support 






























guidelines in the 
delivery of health 
care and the 








































● Built a foundation of awareness 
of current laws regarding health 
policy and how to become 
involved through a Health Policy 
course (DNPC 658, Spring 
2019)  
● Developed an understanding of 
the basics of healthcare finance 
to better understand patient, 
staff, and insurance involvement 
in providing adequate health 
care. Gained hands-on 
experience in how to create a 
business plan to promote a 
change to improve patient care 
(DNPC 653, Summer 2019) 
● Gained an understanding of 
cultural humility and how to 
approach diversity among our 
patients through readings and 
discussions in Reflective 
Practice (DNPC 610, Summer 
2019) 
● Gained an understanding of the 
different genetic tests available 
to patients and the appropriate 
use of these tests regarding 
ethical and legal considerations 
(DNPC 622, Fall 2019) 
● Gained experience using an EHR 
in a primary care setting to chart, 
bill, send and receive patient 
referrals. Also utilized resources 
such as Up-to-Date and 
Epocrates to deliver appropriate 
and competent care to patients. 
Also utilized CDC vaccine 
schedule apps to guide 
recommendations for patients 
during primary care 
appointments (NPTC 602, Fall 
2019) 
● Gained an understanding on how 
to properly document a SOAP 
note and gained hands-on 
experience navigating a patient 
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DNP Essential IV: 
Information 
Systems/Technology & 
Patient Care Technology 
for Improvement & 




Technology & Information 





guidelines in the 
delivery of health 
care and the 






chart through OSCEs in our 
simulation lab (APNC 521, Fall 
2019) 
● Created a theoretical EBP 
project that utilized patient 
technology services such as a 
patient portal to share and collect 
data with patients (DNPC 686, 
Spring 2020) 
● Continued to use an EHR in a 
primary care setting to chart, 
bill, send and receive patient 
referrals and utilized Up-to-Date 
and Epocrates to deliver 
appropriate and competent care 
to patients. Also used the CDC 
milestones app, USPSTF and 
ASCVD apps as resources to 
guide clinical practice (NPTC 
604, Spring 2020) 
● Developed an understanding of 
Telehealth practice theories 
through lecture content (NPTC 
605, Summer 2020) and clinical 
application (NPTC 604, Spring 
2020 & NPTC 605/608, Fall 
2020). Also developed a 
foundation for diagnostic 
interpretations of x-ray imaging 
(NPTC 605 & 608, Summer 
2020).  
● Developed an understanding of 
function, clinical use, and gained 
hands-on application with using 
lasers to treat common 
dermatologic conditions (NPTC 
605 & 608, Fall 2020)  
● Gained experience providing 
ethical and compassionate care 
to care to low-income and at-risk 
populations including patients 
with HIV, AIDS, HCV, and 
substance abuse disorders at a 
primary care clinical setting 
(NPTC 609, Spring 2021) 
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DNP Essential V: Health 
Care Policy for Advocacy 





Health care policy, whether 
created through governmental 
actions, institutional decision-
making, or organizational 
standards, creates a framework 
that can facilitate or impede the 
delivery of health care services or 
the ability of the provider to 
engage in practice to address 
health care needs. Engagement in 
the process of policy development 
is central to creating a health 
care system that meets the needs 
of its constituents. Political 
activism and a commitment to 
policy development are central 




efforts to develop 
and implement 
policies to improve 
health care 
delivery and 









● Built a foundation of awareness 
of Health Policy and how to 
become involved through a 
Health Policy course. Within this 
course submitted a policy 
proposal to the ANA regarding 
overuse of medical tests. Gained 
awareness of current 
organizations involved in these 
processes and how to get 
involved (DNPC 658, Spring 
2019). 
DNP Essential VI: 
Interprofessional 
Collaboration for 







Today’s complex, multi-tiered 
health care environment depends 
on the contributions of highly 
skilled and knowledgeable 
individuals from multiple 
professions. In order to 
accomplish the IOM mandate for 
safe, timely, effective, efficient, 
equitable, and patient-centered 
care in this environment, health 
care professionals must function 
as highly collaborative teams. 
DNPs have advanced preparation 
in the interprofessional dimension 
of health care that enable them to 
facilitate collaborative team 
1. Demonstrate 
advanced levels of 
clinical practice 
within defined 

















efforts to develop 
and implement 
policies to improve 
● Built a foundation of awareness 
of Health Policy and how to 
become involved through a 
Health Policy course (DNPC 
658, Spring 2019). Within this 
course submitted a policy 
proposal to the ANA regarding 
overuse of medical tests   
● Gained experience using an EHR 
in a primary care setting to send 
and receive patient referrals from 
other specialties within the 
healthcare system. Collaborated 
with other NPs and Providers 
within the clinic setting to 
provide competent care to 
patients (NPTC 602, Fall 2019) 
● Collaborated with my peers in 
developing accurate physical 
assessment skills in the 
simulation lab (APNC 521, Fall 
2019) 
● Created a theoretical DNP 
project that required 
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functioning and overcome 
impediments to interprofessional 
practice. DNP graduates have 
preparation in methods of 
effective team leadership and are 
prepared to play a central role in 
establishing interprofessional 
teams, participating in the work 
of the team, and assuming 













collaboration between providers, 
nurses, medical assistants, 
clinical managers, and patients 
to improve patient understanding 
and outcomes surrounding 
pediatric eczema management 
(DNPC 686, Spring 2020)  
● Continued to utilize the EHR in 
a primary care setting to send 
and receive patient referrals from 
other specialties within the 
healthcare system. Collaborated 
with other NPs and Providers 
and medical assistants within the 
clinic setting to provide 
competent care to patients 
(NPTC 604, Spring 2020) 
● Became comfortable with a team 
approach to treating 
dermatologic conditions with 
lasers at Scripps Clinic 
Dermatology through hands-on 
collaboration with a nurse 
practitioner and LVN. Also 
became comfortable with 
knowing when to refer patients 
to general dermatology or the 
PCP for continued management 
of medical conditions outside the 
lasers & cosmetic dermatology 
scope of practice (NPTC 605 & 
608, Fall 2020) 
DNP Essential VII: 
Clinical Prevention & 







Consistent with national calls for 
action and with the longstanding 
focus on health promotion and 
disease prevention in nursing, the 
DNP graduate has a foundation 
6. Employ a 
population health 
focus in the design, 
implementation, 






tertiary levels of 
prevention. 
 
● Developed the ability to interpret 
epidemiological data and use 
this data to implement a primary 
prevention program for asthma 
in pediatric patients at public 
school through a project 
completed in DNPC 625 (Fall 
2018) 
● Developed a foundation in health 
promotion and prevention 
through lecture content on social 
determinants of health, change 
theories, health disparities, and 
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in clinical prevention and 
population health. This 
foundation enables DNP 
graduates to analyze 
epidemiological, biostatistical, 
occupational, and environmental 
data in the development, 
implementation, and evaluation of 
clinical prevention and 
population.  
6. Employ a 
population health 
focus in the design, 
implementation, 






tertiary levels of 
prevention. 
the differences between primary, 
secondary, and tertiary care. 
Became familiar with ACOG, 
AAP, USPSTF and their 
recommendations for 
preventative screenings and care 
(NPTC 602, Fall 2019). 
● Analyzed current eczema 
management within an allergy 
clinic to determine a need for 
streamlined practice regarding 
patient education to improve 
patient outcomes for a mock 
EBP project (DNPC 686, Spring 
2020)  
● Continued to develop a 
foundation in health promotion 
and prevention through lecture 
content on bias, cross cultural 
care, patient privacy, and ethical 
decision making. Continued to 
utilize ACOG, AAP, and 
USPSTF recommendations for 
preventative screenings in 
primary care setting (NPTC 604, 
Spring 2020). 
● Perform skin checks and 
treatment of actinic keratoses 
with liquid nitrogen and PDT to 
prevent progression of the 
lesions to skin cancer at a 
dermatology clinical setting. 
Also provided patient education 
regarding proper skin care and 
protection (NPTC 605 & 608, 
Fall 2020)  







Competencies The increased 
knowledge and sophistication of 
1. Demonstrate 
advanced levels of 
clinical practice 
within defined 





• Gained and understanding of 
cultural humility and how to 
approach diversity among our 
patients through readings and 
discussions in Reflective 
Practice. Also practiced 
reflection and mindfulness 
throughout the course to learn 
how to provide culturally 
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health care has resulted in the 
growth of specialization in 
nursing in order to ensure 
competence in these highly 
complex areas of practice. The 
reality of the growth of 
specialization in nursing practice 
is that no individual can master 
all advanced roles and the 
requisite knowledge for enacting 
these roles. DNP programs 
provide preparation within 
distinct specialties that require 
expertise, advanced knowledge, 
and mastery in one area of 
nursing practice. A DNP 
graduate is prepared to practice 
in an area of specialization within 









competent and therapeutic 
interventions for our patients 
(DNPC 610, Summer 2019) 
• Gained an understanding of 
when to refer patients with 
complex multi-system 
conditions to or when to consult 
with a geneticist for a thorough 
workup and management 
(DNPC 622, Fall 2019) 
• Developed an understanding of 
social determinants of health, 
implicit bias, vaccine hesitancy, 
billing issues, healthcare fraud, 
standardized protocols, practice 
authority, impact of culture, and 
the role of the APRN and 
clinical judgement through 
lectures and class discussions 
(NPTC 602, Fall 2019) 
• Developed physical assessment 
skills for pediatric patients, adult 
patients, and geriatric patients in 
skills lab. These skills have 
prepared me to care for patients 
of all ages in any clinical setting 
(APNC 521, Fall 2019) 
• Developed an advanced 
knowledge of eczema 
management in the pediatric 
population through evaluation of 
practices at an allergy clinic and 
conduction of a literature review 
for a mock EBP project (DNPC 
686, Spring 2020) 
• Developed an advanced 
knowledge and gained hands on 
experience within the laser & 
cosmetic dermatology 
subspecialty (NPTC 605 & 608, 
Fall 2020) 
• Gained experience with 
providing ethical care to 
underserved populations with 
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HIV, AIDS, HCV, and STDs 
using practice guidelines in a 
primary care clinical setting. 
Also implement levels of 
primary, secondary, and tertiary 
prevention when caring for these 
populations using guidelines 
from USPSTF and the CDC 



















































Caregiver Comprehension of Eczema Action Plan 
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Appendix F 
Certificates  
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